Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: A new classification from the European Society for Blood and Marrow Transplantation
| dc.contributor.author | Mohty, Mohamad | |
| dc.contributor.author | Malard, Florent | |
| dc.contributor.author | Abecassis, Manuel | |
| dc.contributor.author | Aerts, Erik | |
| dc.contributor.author | Alaskar, Ahmed S. | |
| dc.contributor.author | Aljurf, Mahmoud Deeb | |
| dc.contributor.author | Arat, Mutlu Ersöz | |
| dc.contributor.author | Bader, Peter | |
| dc.contributor.author | Baron, Frédéric A. | |
| dc.contributor.author | Bazarbachi, Ali Abdul Hamid | |
| dc.contributor.author | Blaise, Didier P. | |
| dc.contributor.author | Ciceri, Fabio | |
| dc.contributor.author | Corbacioglu, Selim | |
| dc.contributor.author | Dalle, Jean Hugues H. | |
| dc.contributor.author | Dignan, Fiona L. | |
| dc.contributor.author | Fukuda, Takahiro | |
| dc.contributor.author | Huynh, Anne | |
| dc.contributor.author | Masszi, Tamás | |
| dc.contributor.author | Michallet, Mauricette C. | |
| dc.contributor.author | Nagler, Arnon | |
| dc.contributor.author | NíChonghaile, Mairéad | |
| dc.contributor.author | Okamoto, Syuuichirou ichiro | |
| dc.contributor.author | Pagliuca, Antonio | |
| dc.contributor.author | Peters, Christina | |
| dc.contributor.author | Petersen, Finn Bo | |
| dc.contributor.author | Richardson, Paul Gerard | |
| dc.contributor.author | Ruutu, Tapani | |
| dc.contributor.author | Savani, Bipin N. | |
| dc.contributor.author | Wallhult, Elisabeth | |
| dc.contributor.author | Yakoub-Agha, Ibrahim | |
| dc.contributor.author | Duarte, Rafael F. | |
| dc.contributor.author | Carreras, Enric | |
| dc.contributor.department | Internal Medicine | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:48:29Z | |
| dc.date.available | 2025-01-24T11:48:29Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Sinusoidal obstruction syndrome, also known as veno-occlusive disease (SOS/VOD), is a potentially life threatening complication that can develop after hematopoietic cell transplantation. Although SOS/VOD progressively resolves within a few weeks in most patients, the most severe forms result in multi-organ dysfunction and are associated with a high mortality rate (>80%). Therefore, careful attention must be paid to allow an early detection of SOS/VOD, particularly as drugs have now proven to be effective and licensed for its treatment. Unfortunately, current criteria lack sensitivity and specificity, making early identification and severity assessment of SOS/VOD difficult. The aim of this work is to propose a new definition for diagnosis, and a severity-grading system for SOS/VOD in adult patients, on behalf of the European Society for Blood and Marrow Transplantation. © 2016 Macmillan Publishers Limited. | |
| dc.identifier.doi | https://doi.org/10.1038/bmt.2016.130 | |
| dc.identifier.eid | 2-s2.0-84968571756 | |
| dc.identifier.pmid | 27183098 | |
| dc.identifier.uri | http://hdl.handle.net/10938/30819 | |
| dc.language.iso | en | |
| dc.publisher | Nature Publishing Group | |
| dc.relation.ispartof | Bone Marrow Transplantation | |
| dc.source | Scopus | |
| dc.subject | Adult | |
| dc.subject | Biomarkers | |
| dc.subject | Early diagnosis | |
| dc.subject | Hematopoietic stem cell transplantation | |
| dc.subject | Hepatic veno-occlusive disease | |
| dc.subject | Humans | |
| dc.subject | Risk factors | |
| dc.subject | Sensitivity and specificity | |
| dc.subject | Severity of illness index | |
| dc.subject | Antithrombin iii | |
| dc.subject | Bilirubin | |
| dc.subject | Blood clotting factor 7 | |
| dc.subject | Busulfan | |
| dc.subject | Cyclophosphamide | |
| dc.subject | Cyclosporin | |
| dc.subject | Defibrotide | |
| dc.subject | Methotrexate | |
| dc.subject | Norethisterone | |
| dc.subject | Plasminogen activator inhibitor 1 | |
| dc.subject | Protein c | |
| dc.subject | Rapamycin | |
| dc.subject | Tacrolimus | |
| dc.subject | Von willebrand factor | |
| dc.subject | Biological marker | |
| dc.subject | Allogeneic hematopoietic stem cell transplantation | |
| dc.subject | Article | |
| dc.subject | Ascites | |
| dc.subject | Autologous hematopoietic stem cell transplantation | |
| dc.subject | Diagnostic imaging | |
| dc.subject | Differential diagnosis | |
| dc.subject | Disease severity | |
| dc.subject | Drug megadose | |
| dc.subject | Genital bleeding | |
| dc.subject | Graft versus host reaction | |
| dc.subject | Hepatomegaly | |
| dc.subject | Heredity | |
| dc.subject | Hla matching | |
| dc.subject | Human | |
| dc.subject | Hyperbilirubinemia | |
| dc.subject | Iron overload | |
| dc.subject | Karnofsky performance status | |
| dc.subject | Kidney failure | |
| dc.subject | Liver dysfunction | |
| dc.subject | Liver venoocclusive disease | |
| dc.subject | Mortality rate | |
| dc.subject | Multiple organ failure | |
| dc.subject | Myeloablative conditioning | |
| dc.subject | Portal hypertension | |
| dc.subject | Priority journal | |
| dc.subject | Prognosis | |
| dc.subject | Reduced intensity conditioning | |
| dc.subject | T cell depletion | |
| dc.subject | Thrombocytopenia | |
| dc.subject | Weight gain | |
| dc.subject | Whole body radiation | |
| dc.subject | Liver vein obstruction | |
| dc.subject | Risk factor | |
| dc.title | Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: A new classification from the European Society for Blood and Marrow Transplantation | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1